Ulcerative colitis
Conditions
Interventions
Mesalazine group:Mesalazine enteric-coated tablets 2 tablets three times a day orally.
combination group:Chinese medicine formula granule (Guangdong Yifang Pharmaceutical Co., Ltd, Foshan, China) will be taken one dose a day with warm water, morning and evening, combing with Mesalazine
Sponsors
Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients diagnosed with mild to moderate UC activity (modified Mayo score 3-10, endoscopic score >1); (2) TCM syndrome differentiation is intestinal damp-heat syndrome; (3)18-75 (inclusive) years old, voluntarily sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe complications, such as toxic mega-colon, intestinal obstruction, intestinal perforation, massive bleeding, colorectal cancer. (2) People with other intestinal diseases, such as bacillary dysentery, intestinal conjunctibles, Crohn's disease. (3) A person who is pregnant, breastfeeding or trying to become pregnant. (4) Patients with serious primary diseases such as heart, brain, lung, kidney, liver, hematopoietic system, and malignant tumors. (5) Those who are allergic to prescription ingredients or treatment contraindications. (6) Participants who have participated in other clinical trials in the past 4 weeks. (7) Others judged by the researcher to be unsuitable for the situation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mayo Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| UCEIS;IBD-Q;TCM symptom score for gastrointestinal diseases; | — |
Countries
China
Contacts
Public ContactXia Ding
Beijing University of Chinese Medicine
Outcome results
None listed